Small-angle neutron scattering study of coal extract solutions in pyridine
β Scribed by R. Triolo; H.R. Child
- Publisher
- Elsevier Science
- Year
- 1984
- Tongue
- English
- Weight
- 646 KB
- Volume
- 63
- Category
- Article
- ISSN
- 0016-2361
No coin nor oath required. For personal study only.
β¦ Synopsis
Three perdeutero-pyridine extracts of Illinois No. 6 coal were studied with SANS in an effort to: 1. check the reproducibility of the measurements; 2. check the reproducibility of the extractions; and 3. try to measure weight average molecular weights for the non-fractionated extracts. In addition one sample from the Bruceton mine of Pennsylvania was studied to check any dependence on the coal's origin and one silylated sample of an Illinois No. 6 extract was studied to assess the effect of chemical treatment of coals on the average molecular weight. The chemical composition and the number-average molecular weights were obtained for the same samples. Scattering data were observed to be well represented by the Debye theory for a random two phase system with an experimental densitydensity correlation function described by a correlation length a. The analysis of the data shows that the extraction is a non-reproducible operation and this seems to be due to the heterogeneous nature of coal. In addition the present methods available to obtain molecular weights from the scattering data do not seem to be applicable to coal extracts.
π SIMILAR VOLUMES
Pore size distribution functions of coals of different rank obtained from small-angle neutron scattering data are quantitatively consistent with data obtained from adsorption measurements. The agreement will provide a firm foundation for using SANS to probe coal porosity under conditions where conve
## Abstract The present study investigates shape properties of the enzyme dUTPase from Escherichia coli in the solution phase. In this work small angle neutron scattering (SANS) findings on dUTPase/D~2~O solutions for temperature values of __T__β=β8βΒ°C and __T__β=β37βΒ°C are presented. The analysis
Recombinant gelatins are currently evaluated as new excipients for pharmaceutical formulations. They can differ from nonrecombinant gelatins because of intentional alteration of the amino acid sequence and specific properties of the expression systems used. This may affect their solution behavior. I